IntraSense™ – Medical Device Biocompatibility
MILPITAS, Calif.--(BUSINESS WIRE)--Mar 12, 2019--SMI (Silicon Microstructures, Inc.) is pleased to announce that biocompatibility of IntraSense™ has been confirmed at a major medical device manufacturer. Biocompatibility is a critical factor during the design of an invasive medical device and the compliance of IntraSense™ parts ensures easy integration into a variety of minimally invasive applications. The IntraSense™ product line will be the focus of SMI’s exhibition at SIR2019, the annual meeting of the Society of Interventional Radiology.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190312005739/en/
IntraSenseTM biocompatibility and stable performance has been confirmed through extensive testing (Graphic: Business Wire)
The IntraSense™ line of pressure sensing solutions simplifies direct pressure monitoring throughout the anatomy leveraging industry leading size of less than 1-French. It is designed to enable accurate in vivo pressure sensing in many minimally invasive devices, including catheters and endoscopes. To ensure easy system integration, the sensor can be directly exposed to different bodily fluids with no encapsulation required. IntraSense™ biocompatibility and stable performance has now been confirmed through extensive testing.
“Independent testing by third parties is an important part of our product development,” explains Dr. Justin Gaynor, Vice President, IntraSense™ Product Line. “Our customer confirmed that their device, in which IntraSense is exposed directly to the bloodstream, showed reactivity grades of zero for cytotoxicity, sensitization and intracutaneous reactivity. It was rated non-toxic, non-pyrogenic and non-hemolytic. Finally, it was found non-activating in thrombolytic and SC5b-9 tests. We are very pleased that these results will speed our customer’s efforts as they develop a best-in-class catheter for their life-critical application.”
For more information visit the IntraSense™ Product Page.
Exhibit at Society of Interventional Radiology Meeting
SMI is excited to announce their participation at SIR2019 in Austin, Texas, March 24 through March 27. IntraSense™ will be of general interest to the interventional radiology community and equipment OEMs that supply them. With its minimal size, various environments capability and accurate measurements the IntraSense™ line of in vivo pressure sensors opens the door to advance existing Interventional Radiology diagnostics and procedures while enabling new designs, to improve patient outcome. Booth visitors have the opportunity to learn more about the benefits of IntraSense™, showcased on the new IntraSense™ application demonstrator. SMI looks forward to welcoming visitors at booth 300.
Silicon Microstructures, Inc. (SMI) is a member of the worldwide Elmos Semiconductor Group, developing, producing and marketing semiconductors and sensors. SMI is an ISO certified premier developer and manufacturer of MEMS-based pressure sensors offering unique solutions for pressure and flow sensing. SMI empowers invasive medical devices with ultra-small sensors for in vivo pressure measurement. SMI’s design, production and quality control processes have enabled it to develop both the lowest pressure and smallest pressure sensors available on the market today.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190312005739/en/
CONTACT: Anja Carranza
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA
INDUSTRY KEYWORD: TECHNOLOGY HARDWARE SEMICONDUCTOR HEALTH MEDICAL DEVICES
SOURCE: Silicon Microstructures, Inc.
Copyright Business Wire 2019.
PUB: 03/12/2019 01:00 PM/DISC: 03/12/2019 01:01 PM